NCT06556381

Brief Summary

Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2024

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

August 1, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 16, 2024

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

4 months

First QC Date

August 1, 2024

Last Update Submit

August 13, 2024

Conditions

Analgesia

Keywords

Paincesarean delivery

Outcome Measures

Primary Outcomes (1)

  • Pain Score

    NRS

    24 hours

Study Arms (2)

Group A,

EXPERIMENTAL

women who received TAP block.

Procedure: TAP block

Group B

ACTIVE COMPARATOR

Received Usual modality of analgesics (Paracetamol, Tramadol, and Pethidine).

Procedure: TAP block

Interventions

TAP blockPROCEDURE

Women will receive TAP block.

Group A,Group B

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 20-50 years
  • Patients of \>50 kg or \<100 kg weight.
  • Urgency: Elective, Emergent and Urgent cases

You may not qualify if:

  • Patients of \<50 kg or \>100 kg weight
  • Any contraindication to any of anesthesia medications
  • Patient unable to understand numeric rating scale (NRS)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Qassim University Medical City

Buraidah, Al-Qassim Region, 51411, Saudi Arabia

RECRUITING

MeSH Terms

Conditions

AgnosiaPain

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mohammed Abaalkhayl, MD

    Qassim University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

HANI ALNAJJAR, BSN

CONTACT

00966553873999hanialnajjar88@gmail.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Proffesor

Study Record Dates

First Submitted

August 1, 2024

First Posted

August 16, 2024

Study Start

April 1, 2024

Primary Completion

July 30, 2024

Study Completion

August 30, 2024

Last Updated

August 16, 2024

Record last verified: 2024-08

Locations

SA(1)